Literature DB >> 28379354

Motor neuronal repletion of the NMJ organizer, Agrin, modulates the severity of the spinal muscular atrophy disease phenotype in model mice.

Jeong-Ki Kim1,2, Charlotte Caine1,2, Tomoyuki Awano1,2, Ruth Herbst3,4, Umrao R Monani1,2,5.   

Abstract

Spinal muscular atrophy (SMA) is a common and often fatal neuromuscular disorder caused by low levels of the Survival Motor Neuron (SMN) protein. Amongst the earliest detectable consequences of SMN deficiency are profound defects of the neuromuscular junctions (NMJs). In model mice these synapses appear disorganized, fail to mature and are characterized by poorly arborized nerve terminals. Given one role of the SMN protein in orchestrating the assembly of spliceosomal snRNP particles and subsequently regulating the alternative splicing of pre-mRNAs, a plausible link between SMN function and the distal neuromuscular SMA phenotype is an incorrectly spliced transcript or transcripts involved in establishing or maintaining NMJ structure. In this study, we explore the effects of one such transcript-Z+Agrin-known to be a critical organizer of the NMJ. We confirm that low SMN protein reduces motor neuronal levels of Z+Agrin. Repletion of this isoform of Agrin in the motor neurons of SMA model mice increases muscle fiber size, enhances the post-synaptic NMJ area, reduces the abnormal accumulation of intermediate filaments in nerve terminals of the neuromuscular synapse and improves the innervation of muscles. While these effects are independent of changes in SMN levels or increases in motor neuron numbers they nevertheless have a significant effect on the overall disease phenotype, enhancing mean survival in severely affected SMA model mice by ∼40%. We conclude that Agrin is an important target of the SMN protein and that mitigating NMJ defects may be one strategy in treating human spinal muscular atrophy.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28379354      PMCID: PMC6074815          DOI: 10.1093/hmg/ddx124

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  46 in total

1.  A mouse model for spinal muscular atrophy.

Authors:  H M Hsieh-Li; J G Chang; Y J Jong; M H Wu; N M Wang; C H Tsai; H Li
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

2.  Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number.

Authors:  P E McAndrew; D W Parsons; L R Simard; C Rochette; P N Ray; J R Mendell; T W Prior; A H Burghes
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

3.  SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN.

Authors:  Thanh T Le; Lan T Pham; Matthew E R Butchbach; Honglai L Zhang; Umrao R Monani; Daniel D Coovert; Tatiana O Gavrilina; Lei Xing; Gary J Bassell; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2005-02-09       Impact factor: 6.150

4.  Rescuing Z+ agrin splicing in Nova null mice restores synapse formation and unmasks a physiologic defect in motor neuron firing.

Authors:  Matteo Ruggiu; Ruth Herbst; Natalie Kim; Marko Jevsek; John J Fak; Mary Anne Mann; Gerald Fischbach; Steven J Burden; Robert B Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-12       Impact factor: 11.205

5.  MuSK controls where motor axons grow and form synapses.

Authors:  Natalie Kim; Steven J Burden
Journal:  Nat Neurosci       Date:  2007-12-16       Impact factor: 24.884

Review 6.  The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy.

Authors:  James N Sleigh; Thomas H Gillingwater; Kevin Talbot
Journal:  Dis Model Mech       Date:  2011-07       Impact factor: 5.758

7.  Cryorecovery of Mouse Sperm by Different IVF Methods Using MBCD and GSH.

Authors:  Ming-Wen Li; Olivia C Glass; Jasmin Zarrabi; Lisa N Baker; K C Kent Lloyd
Journal:  J Fertili In Vitro       Date:  2016-03-18

8.  Structural domains of agrin required for clustering of nicotinic acetylcholine receptors.

Authors:  W Hoch; J T Campanelli; S Harrison; R H Scheller
Journal:  EMBO J       Date:  1994-06-15       Impact factor: 11.598

9.  A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy.

Authors:  Umrao R Monani; Matthew T Pastore; Tatiana O Gavrilina; Sibylle Jablonka; Thanh T Le; Catia Andreassi; Jennifer M DiCocco; Christian Lorson; Elliot J Androphy; Michael Sendtner; Michael Podell; Arthur H M Burghes
Journal:  J Cell Biol       Date:  2003-01-06       Impact factor: 10.539

10.  Acetylcholine receptor-aggregating activity of agrin isoforms and mapping of the active site.

Authors:  M Gesemann; A J Denzer; M A Ruegg
Journal:  J Cell Biol       Date:  1995-02       Impact factor: 10.539

View more
  14 in total

1.  AAV9-DOK7 gene therapy reduces disease severity in Smn2B/- SMA model mice.

Authors:  Kevin A Kaifer; Eric Villalón; Caley E Smith; Madeline E Simon; Jose Marquez; Abigail E Hopkins; Toni I Morcos; Christian L Lorson
Journal:  Biochem Biophys Res Commun       Date:  2020-07-30       Impact factor: 3.575

2.  Motor neuron biology and disease: A current perspective on infantile-onset spinal muscular atrophy.

Authors:  Narendra N Jha; Jeong-Ki Kim; Umrao R Monani
Journal:  Future Neurol       Date:  2018-07-06

3.  HuD and the Survival Motor Neuron Protein Interact in Motoneurons and Are Essential for Motoneuron Development, Function, and mRNA Regulation.

Authors:  Thi Hao le; Phan Q Duy; Min An; Jared Talbot; Chitra C Iyer; Marc Wolman; Christine E Beattie
Journal:  J Neurosci       Date:  2017-10-23       Impact factor: 6.167

Review 4.  Curing SMA: Are we there yet?

Authors:  Aoife Reilly; Lucia Chehade; Rashmi Kothary
Journal:  Gene Ther       Date:  2022-05-26       Impact factor: 5.250

5.  Chronic Pharmacological Increase of Neuronal Activity Improves Sensory-Motor Dysfunction in Spinal Muscular Atrophy Mice.

Authors:  Christian M Simon; Beatriz Blanco-Redondo; Jannik M Buettner; John G Pagiazitis; Emily V Fletcher; Josiane K Sime Longang; George Z Mentis
Journal:  J Neurosci       Date:  2020-11-20       Impact factor: 6.167

6.  Increasing Agrin Function Antagonizes Muscle Atrophy and Motor Impairment in Spinal Muscular Atrophy.

Authors:  Marina Boido; Elena De Amicis; Valeria Valsecchi; Marco Trevisan; Ugo Ala; Markus A Ruegg; Stefan Hettwer; Alessandro Vercelli
Journal:  Front Cell Neurosci       Date:  2018-01-30       Impact factor: 5.505

7.  MYO9A deficiency in motor neurons is associated with reduced neuromuscular agrin secretion.

Authors:  Emily O'Connor; Vietxuan Phan; Isabell Cordts; George Cairns; Stefan Hettwer; Daniel Cox; Hanns Lochmüller; Andreas Roos
Journal:  Hum Mol Genet       Date:  2018-04-15       Impact factor: 6.150

8.  Effects of Graphene Oxide Nanofilm and Chicken Embryo Muscle Extract on Muscle Progenitor Cell Differentiation and Contraction.

Authors:  Jaśmina Bałaban; Mateusz Wierzbicki; Marlena Zielińska; Jarosław Szczepaniak; Malwina Sosnowska; Karolina Daniluk; Dominik Cysewski; Piotr Koczoń; André Chwalibog; Ewa Sawosz
Journal:  Molecules       Date:  2020-04-23       Impact factor: 4.411

9.  A cell autonomous torsinA requirement for cholinergic neuron survival and motor control.

Authors:  Samuel S Pappas; Jay Li; Tessa M LeWitt; Jeong-Ki Kim; Umrao R Monani; William T Dauer
Journal:  Elife       Date:  2018-08-17       Impact factor: 8.140

10.  ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy.

Authors:  Annapoorna Kannan; Xiaoting Jiang; Lan He; Saif Ahmad; Laxman Gangwani
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.